Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old

Amblyopia Clinical Trial

— ATS13  

Official title:

An Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00669539
• Other study ID #: NEI-139
• Secondary ID: 2U10EY011751
• Status: Completed
• Phase: N/A
• First received: April 28, 2008
• Last updated: July 7, 2016
• Start date: May 2008
• Est. completion date: December 2010

Study information

• Verified date: July 2016
• Source: Jaeb Center for Health Research
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

This study will evaluate the effectiveness of refractive correction alone for the treatment of previously untreated strabismic or combined-mechanism amblyopia in children 3 to <7 years old with visual acuity of 20/40 to 20/400

Description:

This study will evaluate the effectiveness of refractive correction alone for the treatment of previously untreated strabismic or combined-mechanism amblyopia in children 3 to <7 years old with visual acuity of 20/40 to 20/400.

A recently completed PEDIG study (ATS5) found that in 3 to < 7-year-old children with previously untreated anisometropic amblyopia, refractive correction alone improved visual acuity by 2 or more lines in 77% of the patients and amblyopia resolved in at least one third of the patients. These results supported previous observations from retrospective and pilot studies as well as Stewart et al's prospective report on 18 children with anisometropic amblyopia whose visual acuity improved after treatment with spectacle correction only.

Improvement in amblyopic eye visual acuity from treatment with optimum refractive correction in cases of anisometropic amblyopia is plausible because the refractive correction treats the underlying amblyogenic condition (i.e., uncorrected unequal refractive error) by providing retinal images of more similar clarity, size, and contrast. Elimination of the dissimilar retinal images, which may act as barriers to normal visual input, allows the amblyopic eye to receive appropriate visual stimulation. In contrast, visual acuity improvement with refractive correction alone in cases of amblyopia associated with strabismus is not expected to occur when the refractive correction does not completely eliminate the strabismus and restore fusion. In such cases, the underlying amblyogenic factor of a manifest ocular deviation remains; consequently, active cortical inhibition is presumably still present. Nonetheless, Stewart and colleagues recently reported finding gains in amblyopic eye visual acuity of children with strabismic and combined-mechanism amblyopia after a period of treatment with refractive correction alone. The PEDIG also observed this to occur in a subgroup of children with previously untreated strabismic and combined-mechanism amblyopia in a recent study. Amblyopic eye acuity improved by >= 2 lines from spectacle-corrected baseline acuity in 9 (75%; 95% CI = 43% - 95%) of the 12 patients with strabismic amblyopia and in 9 (69%, 95% CI = 39% - 91%) of the 13 patients with combined-mechanism amblyopia. Mean change from baseline to maximum improvement was 2.2 +- 1.8 and 2.6 +- 2.0 lines, respectively. These results are similar to those of Stewart and colleagues who reported visual acuity improvement averaging 3.0 lines in 16 children with strabismic amblyopia and 1.9 lines in 31 children with combined-mechanism amblyopia.

Although our results support the suggestion of Stewart et al. that strabismic amblyopia can improve with spectacle correction alone, they are not conclusive because both studies had small numbers of patients. Also, our classification of strabismus was based on alignment without refractive correction. Thus, a larger controlled study is needed to confirm or refute these findings in patients with strabismic and combined-mechanism amblyopia.

The ideal study design to answer the question of whether spectacles alone can significantly improve amblyopic eye visual acuity in strabismic children is a randomized trial with a control group who does not receive optical correction. However, most pediatric eye care providers would be reluctant to randomize esotropic children with hyperopic refractive error to a control group of no optical correction because of the likelihood of some children having accommodative esotropia, which would necessitate that hyperopic spectacles be prescribed. The number of esotropic amblyopes without an accommodative component is sufficiently few to make a randomized trial not feasible. Therefore, we have chosen to perform an observational study with a large number of children with pure strabismic and combined-mechanism amblyopia in order to evaluate the effect of refractive correction in this population of patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 156
• Est. completion date: December 2010
• Est. primary completion date: May 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 3 Years to 6 Years

Eligibility

Inclusion Criteria:

• Age 3 to <7 years old

• Able to perform visual acuity testing using the ATS single-surround HOTV protocol

• Amblyopia associated with strabismus (comitant or incomitant) with or without anisometropia

*At least one of the following criteria must be met:

• Heterotropia at distance and/or near fixation on examination (without spectacles)

• History of strabismus surgery (or botulinum toxin extraocular muscle injection)

• Documented history of strabismus that is no longer present (and which in the judgment of the investigator is the cause of amblyopia)

• Visual acuity measured in each eye according to the protocol procedures that meet the following criteria:

• Amblyopic eye 20/40 to 20/400 inclusive

• Sound eye >=20/40

• Inter-eye acuity difference >= 3 logMAR lines (i.e., amblyopic eye acuity at least 3 logMAR lines worse than sound eye acuity)

• No previous spectacle correction

• Refractive error meeting at least 1 of the following criteria: >= 1.00D of astigmatism in the amblyopic eye, >= 1.00D spherical equivalent anisometropia, or >= +2.00D spherical equivalent hyperopia in either eye.

• Investigator wishes to prescribe spectacles to correct refractive error

• Nystagmus per se does not exclude the patient if the above visual acuity criteria are met

• Ocular examination within 2 months prior to enrollment

• Cycloplegic refraction within 2 months prior to enrollment

• No myopia = -0.25D spherical equivalent)

• Parent understands protocol and is willing to accept treatment

• Parent has home phone (or access to phone) and is willing to be contacted by Jaeb Center staff

• Relocation outside of area of an active ATS site within next 6 months not anticipated

Exclusion Criteria:

• Prior amblyopia treatment

• Current vision therapy or orthoptics

• Ocular cause for reduced visual acuity

• Prior intraocular or refractive surgery

• Strabismus surgery planned in the 9 weeks following the Baseline Visit

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Amblyopia

Locations

Country	Name	City	State
United States	Southern California College of Optometry	Fullerton	California

Sponsors (2)

Lead Sponsor	Collaborator
Jaeb Center for Health Research	National Eye Institute (NEI)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Writing Committee for the Pediatric Eye Disease Investigator Group, Cotter SA, Foster NC, Holmes JM, Melia BM, Wallace DK, Repka MX, Tamkins SM, Kraker RT, Beck RW, Hoover DL, Crouch ER 3rd, Miller AM, Morse CL, Suh DW. Optical treatment of strabismic and — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mean Amblyopic Eye Visual Acuity Improvement With Spectacles	Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.	Enrollment to 18 Weeks	No